The American College of Gastroenterology (ACG) is pleased to announce the publication of a new ACG Clinical Guideline on Disorders of Hepatic and Mesenteric Circulation, which was published online today in The American Journal of Gastroenterology.
Disorders of the mesenteric, portal, and hepatic veins and mesenteric and hepatic arteries have important clinical consequences and may lead to acute liver failure, chronic liver disease, noncirrhotic portal hypertension, cirrhosis, and hepatocellular carcinoma. These common disorders play an important role as precipitating factors for the development and progression of complications in patients with existing chronic liver diseases.
The guidelines offer evidence-based recommendations on the following clinical challenges:
- bleeding and thrombotic risk in cirrhosis,
- portal and mesenteric vein thrombosis in patients with and without cirrhosis,
- Budd-Chiari Syndrome,
- mesenteric artery aneurysms, and
- hereditary hemorrhagic telangiectasia (HHT).
New biomarker could predict response to IBD treatment